series-b
Stage
1
Investors
About
Cognition Therapeutics develops drug candidates that target the underlying mechanisms of neurodegenerative diseases such as Alzheimer's disease.
Explore Cognition Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.